Chad Floe appointed as Operating Partner and Managing Director Corporate Finance

Dubai, 24 November 2014: TVM Capital Healthcare Partners announces the addition of Charles P. (Chad) Floe as an Operating Partner at TVM Operations Group DMCC, its accelerator company and Managing Director, Corporate Finance, at its regional healthcare research and advisory company, TVM Healthcare Advisors.

Mr. Floe has been appointed to the senior leadership team of the group of companies to advise, develop and build TVM Capital Healthcare Partner’s portfolio companies by exploring opportunities for M&A, equity and debt financings, as well as partnerships to foster further growth within their home countries and internationally. TVM Capital Healthcare Partners has invested in several healthcare companies in the Middle East and India including Cambridge Medical & Rehabilitation Center, Bourn Hall International, ProVita International Medical Center and Manzil Health Care Services. Very recently the firm launched a mandatory tender offer to buy a majority shareholding in publicly-listed Egyptian medical device company, Ameco Medical Industries.

Dr Helmut Schuehsler, Chairman and CEO of TVM Capital Healthcare Partners, commented: “Chad brings extensive experience in complex corporate transactions and management experience internationally and specifically across the Middle East and India. This special combination of long-standing Middle East and deep healthcare expertise combined with worldwide networks in the industry and a 30-year banking career makes Chad a key hire for us. He has been a trusted advisor to TVM Capital and its portfolio companies for more than 15 years, and we are very excited to now welcome Chad to TVM Capital Healthcare Partners in this important role.”

Added Chad Floe: “TVM Capital has a unique mix of capabilities and several companies that as a group focus on investing in and building world-class healthcare businesses in the MENA region and India together with their international clinical partners. In recent years they have successfully grown a series of emerging businesses with great potential for the region, and I am very excited to be joining their team, particularly with the managements and boards of their portfolio companies to deliver value to their communities and investors.”

Over a career spanning 27 years, Mr. Floe has built and led international mutli-cultural investment banking teams focused on healthcare and cross border advisory. He advised clients in more than 200 M&A, equity, and leveraged finance transactions in Europe, the USA and the Middle East. He currently serves as a board director at Ottobock, a German private medtech company and HealthRight, an international not-for-profit organization (previously “Doctors of the World USA”).
In terms of his operational roles, he has most recently served as International Director at HCA International (London’s leading private hospital operator) where he was focusing on international partnerships in various healthcare verticals and countries, in particular, India and the Middle East. Prior to joining HCA, he was a Managing Director and Head of International Coverage Group & Healthcare at HSBC Investment Bank, London; Head of Advisory, MENA in Dubai, and Head of Cross Border Business Group. Before HSBC, he was a Managing Director & Co-Head of Strategic Growth Industries at Dresdner Kleinwort Wasserstein in London, and a Managing Director, Corporate Finance & Head of International Healthcare at Lehman Brothers. Before Lehman, Mr. Floe held positions at First Boston Corporation as well as JP Morgan in New York and London.
With the TVM Capital Healthcare Partners group of companies, Mr. Floe joins a healthcare investment and advisory group that has declared its goal of establishing global centers of excellence on a local level. In pursuit of this objective, the firm has established clinical affiliations with strong international healthcare institutions such as Bourn Hall Clinics (Cambridge, UK), the Spaulding Rehabilitation Network (a Harvard Medical School teaching hospital) and Joslin Diabetes Center, one of the world’s leading diabetes research, clinical care and education organizations, which is dedicated to the prevention, treatment and cure of diabetes.

TVM Capital Healthcare Partners plans to invest $200 million over the next four years to expand its companies across the MENA region with a focus on the GCC countries, the Levant and Egypt as well as India. It is a member of TVM Capital Group, an affiliation of globally acting venture capital and private equity firms with an operating track record of 30 years.

-Ends-

About TVM Capital Healthcare Partners

TVM Capital Healthcare Partners was established in 2009 under the name TVM Capital MENA and has since then been led by Chairman & CEO, Dr. Helmut M. Schuehsler. The firm is focusing on making highly specialized growth capital and small buyout investments in healthcare companies in the Middle East and North Africa (MENA) region and India that are or target to become leaders in their regional markets.

The firm has assembled a strong team of investment professionals who are supported by a group of healthcare operators as executives-in-residence in its accelerator company, TVM Operations Group, and TVM Healthcare Advisors, which provides healthcare focused research and advisory services. Collectively, this team has developed an ability to conceptualize and develop business opportunities that provide investors with completely proprietary deal flow and investment opportunities.

TVM Capital Healthcare Partners has broken new ground with four portfolio investments to date in specialized services that were either non-existent or drastically undersupplied, e.g., long-term care, rehabilitation, home care and world-class fertility treatment. A fifth investment focuses on the area of medical device development and manufacturing. The firm operates out of the Dubai International Financial Center (DIFC) and is licensed and regulated by the Dubai Financial Services Authority (DFSA). www.tvm-capital.com or www.tvm-capital.ae